Rebecca Mathew

Company: Merck & Co

Job title: Principal Scientist - Discovery & Biology

Seminars:

Panel Discussion: Evaluation of the Current State of Play of Preclinical In Vitro Models 11:00 am

Comparing the benefits of in vitro microglia (iMGs), organoid microglia (oMGs), and xenotransplanted microglia (xMGs) Evaluating existing in vitro systems for modelling neuroinflammation and neurological disorders in humans Exploring future implications for advanced preclinical model developmentRead more

day: Conference Day One

Developing an iPSC-derived Human Microglia Platform to Engineer & Enable a Genetically Enriched Neuroimmune Pipeline 9:30 am

Deciphering the information that can be obtained from neuroimmune iPSC-derived models Applying CRISPR screens to evaluate the functional consequences of genetic perturbations in iPSC-derived human microglia Developing a scalable high-throughput iPSC-derived model system for target validationRead more

day: Conference Day One